Skip to main content

Table 2 ADAR2 edited sites and their relative percentage of editing

From: ADAR2 editing activity in newly diagnosed versus relapsed pediatric high-grade astrocytomas

ADAR2 edited sites

WM

Case 1

Case 2

Case 3

Case 4

(% of editing ± s.e.m.)

(Ctrls)

  

N

R

N

R

N

R

N

R

GluR-B Q/R

100 (±0)

90.3 (±5.6)

92.1 (±0.3)

87.6 (±1.8)

83.5 (±0.9)

98.15 (±1.1)

83 (±0.7)

98.7 (±1.3)

100 (±0)

    R/G

53.2 (±4.2)

21.9 (±6.5)

15.4 (±2)

18.1 (±3.2)

5 (±2.7)

4.4 (±1.4)

7.9 (±1.9)

15.1 (±1.8)

49.3 (±1.8)

GluR-6 I/V

58.1 (±0.7)

20.5 (±3.3)

8.3 (±2.5)

17.1 (±4.8)

12 (±1.5)

0 (±0)

2.7 (±2.7)

12.9 (±1.7)

55.2 (±2.4)

    Y/C

73.5 (±6.9)

32.4 (±0.45)

15.7 (±2)

24.6 (±5.1)

15.7 (±1.8)

6.1 (±0.8)

1.9 (±1.9)

12.7 (±0.3)

82.8 (±3.5)

    Q/R

74.6 (±0.9)

8.6 (±8.6)

3.8 (±3.8)

24.5 (±0.1)

19 (±2.7)

3.4 (±3.4)

6.4 (±0.5)

10.3 (±5.3)

75.9 (±0.9)

GluR-5 Q/R

63.8 (±1)

28.7 (±0.2)

22 (±0.9)

27.6 (±4.6)

20 (±2.2)

16.4 (±2.4)

21.1 (±1.2)

35.9 (±4.9)

71.5 (±3)

Kv1.1 I/V

9.6 (±2)

0 (±0)

0 (±0)

0 (±0)

0 (±0)

0 (±0)

0 (±0)

0 (±0)

10.7 (±1.7)

  1. WM white matter, N newly diagnosed tumor, R recurrent tumor.
  2. % of editing is expressed as mean of three independent experiments ± S.E.M.